How Has the Physiological Saline Market Evolved Historically and What is its Current Size?
The physiological saline market has seen considerable growth due to a variety of factors.
• The physiological saline market has seen strong growth in recent years. It is expected to grow from $6.52 billion in 2024 to $7.11 billion in 2025, with a compound annual growth rate (CAGR) of 9.2%.
This growth is attributed to the increasing adoption of saline solutions in emergency services, rising demand in surgical procedures, a focus on infection control, regulatory standards for sterile saline solutions, and greater awareness of the importance of hydration.
What is the Forecasted Market Size and CAGR for the Physiological Saline Market?
The physiological saline market is expected to maintain its strong growth trajectory in upcoming years.
• The physiological saline market is forecasted to grow to $9.96 billion by 2029, at a CAGR of 8.8%.
Growth is driven by the increasing use of saline in diagnostic procedures, an expanding elderly population, home healthcare services, consumer demand for natural products, and global efforts to improve healthcare access. Major trends include specialized saline formulations, integration with telemedicine, novel formulations, advanced packaging solutions, and safety and efficacy improvements.
What Key Factors and Trends Are Driving The Growth Physiological Saline Market?
Increased surgical procedures are anticipated to provide a boost to the physiological saline market's growth in the future. Surgical procedures are essentially the medical interventions carried out by skilled healthcare providers to diagnose, address, or remedy diseases, injuries, or irregularities in the body through invasive methods that involve incisions, excisions, sutures, or other such manipulations. The escalating numbers of surgical procedures can be credited to factors like improved surgical methodologies, broader access to health care services, and an older population with greater medical requirements, all of which spur the demand for surgical interventions. Physiological saline finds application in surgical procedures for purposes such as cleaning wounds, hydrating tissues, and acting as a medium for irrigation. For example, the Australian Institute of Health and Welfare, a governmental agency based in Australia, reported in December 2023 that in the 2022–23 period, 50% of patients underwent elective surgery within 49 days, a jump from 40 days in the 2021–22 period. Hence, the surge in surgical procedures is fuelling the expansion of the physiological saline market.
What Are The Market Segments In The Physiological Saline Market?
The physiological saline market covered in this report is segmented –
1) By Type: Normal Saline, Hypertonic Saline, Hypotonic Saline
2) By Application: Acute Health Conditions, Chronic Diseases, Skin Abrasions And Burns, Other Applications
3) By End Users: Hospitals, Clinics, Recovery Centers, Other End Users
Subsegments:
1) By Normal Saline: 0.9% Sodium Chloride Solution, Sterile Normal Saline
2) By Hypertonic Saline: 3% Sodium Chloride Solution, 5% Sodium Chloride Solution
3) By Hypotonic Saline: 0.45% Sodium Chloride Solution, 0.225% Sodium Chloride Solution
Pre-Book The Physiological Saline Global Market Report 2025 Report For Swift Delivery And Comprehensive Insights:
Which Emerging Market Trends Are Altering The Physiological Saline Industry?
Leading entities in the physiological saline market are introducing ground-breaking products, for example, premixed hypertonic saline. This innovative product provides a convenient solution for medical professionals to administer the correct dosage of saline in emergency cases swiftly and securely. Premixed hypertonic saline is a sodium chloride solution that has been prepared in advance and contains a greater salt concentration than regular saline. It is commonly utilized in the medical field for treating conditions such as hyponatremia and for lung therapy assistance. To illustrate, Delex Pharma International Inc., an American pharmaceutical production company, introduced Axaline (Sodium Chloride) to the market in April 2024. Axaline, the first premixed 3% hypertonic saline solution intended for severe hyponatremia, is effective in restoring electrolyte balance during conditions like hyponatremia, hypochloremia, and salt deficiency syndrome.
Who Are the Key Players In The Physiological Saline Market?
Major companies operating in the physiological saline market are:
• Cardinal Health Inc.
• Pfizer Inc.
• Fresenius Kabi AG
• Merck KGaA
• Baxter International Inc.
• Otsuka Pharmaceutical Co. Ltd
• Grifols S.A.
• VWR International LLC.
• B Braun Medical Inc
• Spectrum Chemical
• Enzo Life Sciences Inc
• The Stevens Company Limited
• Boreal Science
• HiMedia Laboratories
• AdipoGen Life Sciences Inc
• Thistle Scientific.
• G-Biosciences
• Enzymes Pharmaceuticals
• Labogens
• Hamdan Healthcare
What Are The Regional Insights Into The Physiological Saline Market?
North America was the largest region in the physiological saline market in 2024. The regions covered in the physiological saline market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
